Advocacy and Public Policy
Shaping Public Policy for Nephrology Health Professionals
ASN promotes the highest quality care by serving as the professional organization informing health policy in kidney disease. Click on the magnifying glass to search by keyword or follow links at the left for more information.
ASN comments on Medicare''s decision to repeal final rule on Medicare Coverage of Innovative Technology (MCIT)
Breakthrough technology and therapies are crucial for the millions of Medicare beneficiaries suffering from chronic illness. To ensure patients with kidney disease receive the best coverage and newest innovative devices, ASN urges CMS to move forward on a proposed new rule with an understanding of the need to protect the Medicare program and its beneficiaries.
- Posted Monday, November 15, 2021 @ 11:35 AM
The CY 2022 Medicare Physician Fee Schedule (MPFS) sets reimbursement levels across all physicians billing Medicare. ASN has joined a broad health care coalition to advocate with Congress for a two-year delay in the 3.75% conversion rate and to urge Congress to provide a long-term solution to the budget neutrality provisions that govern MPFS rates.
- Posted Monday, November 15, 2021 @ 11:31 AM
ASN submits comment letter on ESRD Prospective Payment System, ESRD Quality Incentive Program, and ESRD Treatment Choices Model
In a comment letter to CMS Administrator Chiquita Brooks-LaSure, ASN highlights its recommendations for improving the ESRD Prospective Payment System, including TPNIES to increase innovation. Improving the ESRD Quality Incentive Program to illustrate health inequities and alleviate disparities. Improving ESRD ETC model by promoting coordinated care across kidney health systems, promoting intervention earlier to curb the progression of CKD, increase transplantation and home dialysis, and provide more patient centered choices and better clinical outcomes.
- Posted Friday, September 03, 2021 @ 3:16 PM
Representative Jaime Herrera Beutler calls for 3rd vaccine dose to be provided to people with a transplant
Expressing concern on behalf of Americans living with a solid organ transplant or health conditions leading to a compromised immune system, Representative Jaime Herrera Beutler called on HHS Secretary Xavier Becerra to expedite the provision of a 3rd COVID-19 vaccine dose for immunosuppressed and immunocompromised people, as well as study the impact of COVID-19 and different vaccination strategies on transplant recipients and immunocompromised people.
- Posted Wednesday, August 04, 2021 @ 2:27 PM
Representative DelBene's and Representative Bucshon's letter to the U.S. Preventive Services Task Force (USPSTF)
Rep. DelBene and Rep. Bucshon lead a Congressional sign-on letter urging the U.S. Preventive Services Task Force to develop Chronic Kidney Disease screening recommendations to help ease this public health epidemic.
- Posted Monday, August 02, 2021 @ 4:56 PM
ASN submits detailed outline of steps the federal government needs to take to address inequities and barriers to kidney care for minoritized and underserved communities.
In a letter to the White House Office of Management and Budget, ASN highlights the key issues causing disparities in kidney care and provides policy goals to curb these inequities that burden patients with kidney disease.
- Posted Friday, July 16, 2021 @ 2:54 PM
In a letter to AHRQ Acting Director David Meyers, MD, ASN outlines the historical development of estimated glomerular filtration rate (eGFR) and the Kidney Donor Risk Index (KDRI) algorithms and discusses implications of the use of race variables on quality of care and health disparities.
- Posted Friday, May 14, 2021 @ 2:02 PM
ASN provides comments on the interim final rule, "Medicare Coverage of Innovative Technology (MCIT) and Definition of "Reasonable and Necessary" and encourages CMS to provide additional guidance to address any operational difficulties surrounding coding, payment, and benefit category determination.
- Posted Thursday, May 13, 2021 @ 3:50 PM
In a letter to President Biden, ASN has requested the administration coordinate with WHO, other countries, and international organizations, identify and supply necessary medical equipment, and increased vaccine production in order to reduce additional suffering and death around the world.
- Posted Thursday, May 13, 2021 @ 11:17 AM
An unprecedented collaboration among the White House, CDC, ASN, and dialysis organizations across the United States led to the creation of a Partnership to Vaccinate Dialysis Patients which will provide COVID-19 vaccinations to people receiving dialysis and health care personnel in outpatient dialysis clinics.
- Posted Friday, April 16, 2021 @ 10:35 AM
In an effort to prioritize patients with kidney disease for the COVID-19 vaccine, ASN has directly contacted over 40 State Departments of Health requesting patients with kidney failure receiving dialysis, as well as the staff working in dialysis centers who provide this life-saving therapy to be placed in Tier 1a.
- Posted Thursday, April 15, 2021 @ 11:37 AM
ASN requests the Advisory Committee on Immunization Practices (ACIP) and experts at the Center for Disease Control and Prevention (CDC) to protect patients with kidney diseases. People with kidney failure receiving dialysis are some of the very most vulnerable to COVID-19. ASN, therefore, respectfully requests the Advisory Committee prioritize people on dialysis and staff who work in the dialysis environment for receiving vaccination for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and place them in Tier 1a.
- Posted Saturday, December 19, 2020 @ 8:59 AM